Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis

Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

Jean‐Claude Roujeau, Judith P. Kelly, Luigi Naldi et al. · New England Journal of Medicine · 1995 · 1.4K citations

Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

I. Viard, Philippe Wehrli, Roberto Bullani et al. · Science · 1998 · 1K citations

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin

Transfusion Medicine Reviews · 1999 · 871 citations

Clinical Immunology, Toxic Epidermal Necrolysis, Autoimmune Disease +11

Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine

D Mauri-Hellweg, Florence Bettens, Davide Mauri et al. · The Journal of Immunology · 1995 · 348 citations

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

C. Paul, P. Wolkenstein, H. Adle et al. · British Journal of Dermatology · 1996 · 302 citations

Toxic Epidermal Necrolysis, Apoptosis, Stevens-johnson Syndrome +18